It was hypothesized that the activity of ICP therapy relied mostly on pre-existing CD8+ T-cell infiltration.68 For example, Tumeh et al.69 investigated 46 patients with advanced melanoma who received anti-PD-1 therapy. The gene discussed is PDCD1; the disease is melanoma.